logo

Stock Screener

Forex Screener

Crypto Screener

BIOX

Bioceres Crop Solutions Corp. (BIOX)

$

4.42

-0.09 (-2.04%)


Key metrics

Financial statements

Free cash flow per share

Free cash flow per share

0.3395

Market cap

Market cap

282.8 Million

Price to sales ratio

Price to sales ratio

0.7379

Debt to equity

Debt to equity

0.8853

Current ratio

Current ratio

1.0178

Income quality

Income quality

-3.6732

Average inventory

Average inventory

99.8 Million

ROE

ROE

-0.0265



Technology

Technology

Technology – consumer electronics

Largecap

Largecap

With a market cap of 121,78 bil stock is ranked 1

Low risk

Low risk

ISS score of this stock is ranked 1


Company description

Profile

The financial data pertains to the fiscal year 2024. Bioceres Crop Solutions Corp., along with its subsidiaries, recorded an operating income of $44,821,000.00 reflecting its earnings from core operations. The weighted average number of shares outstanding is 62,840,000.00 highlighting the company's shareholder base. Additionally, the company reported depreciation and amortization expenses of $21,295,000.00 which reflects the wear and tear of its assets. The gross profit ratio is 0.39 indicating the efficiency of the company's production and sales operations. Bioceres operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment focuses on developing and commercializing innovative seed technology, including biotechnological events, germplasm, and seed treatments. The Crop Protection segment is engaged in the development, production, and marketing of various products such as Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment specializes in creating, commercializing, and selling inoculants, bio-inductors, and biological and microgranulated fertilizers. Furthermore, the company offers the HB4 drought-tolerant seed technology program, enhancing agricultural adaptability. Based in Rosario, Argentina, the company operates not only in its home country but also in Uruguay, France, South Africa, and internationally. As a small-cap player with a market capitalization of $277,181,736.00 Bioceres Crop Solutions Corp. is recognized as a key player in the Agricultural Inputs industry, contributing significantly to the overall market landscape. The stock is affordable at $4.42 catering to budget-conscious investors who are looking to participate in this innovative sector. However, it is worth noting that the stock has a low average trading volume of 124,356.00 indicating lower market activity, which could influence liquidity. Belonging to the Basic Materials sector, Bioceres drives innovation and growth in agricultural solutions, thereby playing a vital role in optimizing crop productivity.

What is Bioceres Crop Solutions Corp. (BIOX)'s current stock price?

The current stock price of Bioceres Crop Solutions Corp. (BIOX) is $4.23 as of 2025-07-11. Prices may fluctuate during the trading day. For real-time updates, check your brokerage platform or financial news websites.

Investing in Bioceres Crop Solutions Corp. (BIOX) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C-, with a Bearish outlook. Always conduct your own research before investing.

Analysts predict Bioceres Crop Solutions Corp. stock to fluctuate between $3.51 (low) and $11.78 (high) in the next 365 days, reflecting market expectations and potential volatility.

As of 2025-07-11, Bioceres Crop Solutions Corp.'s market cap is $277,181,736, based on 62,710,800 outstanding shares.

Compared to The Sherwin-Williams Company, Bioceres Crop Solutions Corp. has a Lower Market-Cap, indicating a difference in performance.

To buy Bioceres Crop Solutions Corp. (BIOX) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for BIOX. Place an order (Market, Limit, etc.).

The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.

Revenue: $464,829,000 | EPS: $0.05 | Growth: -82.80%.

Visit https://biocerescrops.com/investor-relations for detailed financial reports.

You can explore historical data from here

All-time high: $17.94 (2021-03-16) | All-time low: $3.51 (2025-04-09).

Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.


News

BIOX

businesswire.com

22 days ago

Bioceres Crop Solutions Announces Changes to Board of Directors

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, today announced changes to the composition of its Board of Directors. Noah Kolatch and Scott Crocco are being appointed to the Company's Board of Directors with effect from June 24, 2025. Noah Kolatch is a Principal at Jaspe.

BIOX

seekingalpha.com

a month ago

Bioceres Q3 2025 Illustrates The Financial Challenges And A Distressed Argentinian Market

Bioceres faces mounting financial stress, with Argentina's weak agriculture sector and loss of Syngenta payments driving revenue and EBITDA declines. Cash flow is tightening rapidly; asset sales and one-off inventory benefits are masking underlying losses, while debt and interest costs loom large. Long-term product developments like HB4 and RINO offer potential, but have yet to deliver meaningful, scalable revenue or margin improvements.

BIOX

seekingalpha.com

2 months ago

Bioceres Crop Solutions Corp. (BIOX) Q3 2025 Earnings Call Transcript

Bioceres Crop Solutions Corp. (NASDAQ:BIOX ) Q3 2025 Results Conference Call May 21, 2025 8:30 AM ET Company Participants Paula Savanti - Head, Investor Relations Federico Trucco - Chief Executive Officer Enrique López Lecube - Chief Financial Officer Milen Marinov - Chief Commercial Officer Conference Call Participants Kristen Owen - Oppenheimer Ben Klieve - Lake Street Capital Markets Austin Moeller - Canaccord Steve Byrne - Bank of America Kemp Dolliver - Brookline Capital Markets Operator Hello, everyone, and thank you for joining us on today's Bioceres Crop Solutions Fiscal Third Quarter 2025 Financial and Operational Results. My name is Drew and I'll be the operator on today's call.

BIOX

zacks.com

2 months ago

Bioceres Crop (BIOX) Reports Q3 Loss, Misses Revenue Estimates

Bioceres Crop (BIOX) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to earnings of $0.14 per share a year ago.

BIOX

businesswire.com

2 months ago

Bioceres Crop Solutions Reports Fiscal Third Quarter 2025 Financial and Operational Results

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal third quarter ended March 31, 2025. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in t.

BIOX

businesswire.com

2 months ago

Bioceres Crop Solutions to Host Fiscal Third Quarter 2025 Financial Results Conference Call on Wednesday, May 21, 2025 at 8:30 a.m. Eastern Time

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Wednesday, May 21, 2025 at 8:30 a.m. Eastern Time to discuss its results for the fiscal third quarter ended March 31, 2025. A press release detailing these results will be issued.

BIOX

accessnewswire.com

3 months ago

Moolec Science Enters Into Transformational Transaction Expanding Across Multiple Technology Platforms

LUXEMBOURG, LU / ACCESS Newswire / April 21, 2025 / Moolec Science SA (NASDAQ:MLEC) ("The Company" or "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today announced that it has entered into a Business Combination Agreement (the "BCA") with Bioceres Group Limited ("Bioceres Group") and other related entities in an all-stock transaction (the "Business Combination"). Subject to the terms and conditions of the BCA, which was signed on April 17, 2025, several parties will transfer their respective holdings in Bioceres Group, Nutrecon LLC ("Nutrecon"), and Gentle Technologies Corp ("Gentle Tech", and together with Bioceres Group and Nutrecon, the "Contributed Entities"), resulting in an enlarged corporate structure with Moolec as the parent company.

BIOX

accessnewswire.com

3 months ago

Moolec Science Enters Into Transformational Transaction Expanding Across Multiple Technology Platforms

LUXEMBOURG, LU / ACCESS Newswire / April 21, 2025 / Moolec Science SA (NASDAQ:MLEC) ("The Company" or "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today announced that it has entered into a Business Combination Agreement (the "BCA") with Bioceres Group Limited ("Bioceres Group") and other related entities in an all-stock transaction (the "Business Combination"). Subject to the terms and conditions of the BCA, which was signed on April 17, 2025, several parties will transfer their respective holdings in Bioceres Group, Nutrecon LLC ("Nutrecon"), and Gentle Technologies Corp ("Gentle Tech", and together with Bioceres Group and Nutrecon, the "Contributed Entities"), resulting in an enlarged corporate structure with Moolec as the parent company.

BIOX

businesswire.com

4 months ago

Bioceres Crop Solutions Announces EPA Registration of Rinotec Insecticide and Nematicide Platform, a Game-Changing Solution for Integrated Pest Management

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions (NASDAQ: BIOX), a leading global provider of sustainable crop productivity solutions, and ProFarm Group, a subsidiary of BIOX, today announced that their innovative insecticide and nematicide platform, Rinotec, has received a federal registration from the U.S. Environmental Protection Agency (EPA). Rinotec is exempt from residue tolerance requirements, reflecting the EPA's assessment of its negligible risk to human health and non-targ.

BIOX

businesswire.com

4 months ago

Bioceres Crop Solutions Secures Patent Protection for HB4 Wheat in the U.S. Until 2042

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX), announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its first event-specific patent covering the HB4 Wheat, IND-ØØ412-7. This approval is the first of four potential patents the company is pursuing for HB4 Wheat in the United States, securing protection for this technology and associated production system until 2042. HB4 wheat offers improved t.

See all news

logo
Stocks, Indicators, Pattern screeners all at one place
Stock Screener
Forex Screener
Crypto Screener